Zegalogue is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Zealand Pharma A/s. The primary component is Dasiglucagon.
Product ID | 80644-0013_befd6f41-152c-ca68-e053-2995a90acbc0 |
NDC | 80644-0013 |
Product Type | Human Prescription Drug |
Proprietary Name | Zegalogue |
Generic Name | Dasiglucagon |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2021-04-05 |
Marketing Category | NDA / |
Application Number | NDA214231 |
Labeler Name | Zealand Pharma A/S |
Substance Name | DASIGLUCAGON |
Active Ingredient Strength | 1 mg/.6mL |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-04-05 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
80644-0012 | Zegalogue | dasiglucagon |
80644-0013 | Zegalogue | dasiglucagon |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() ZEGALOGUE 79256691 5905935 Live/Registered |
ZEALAND PHARMA A/S 2019-01-14 |